Skip to main content
TipRanks
Go Ultimate75% OFF

Shanghai Henlius Biotech, Inc. Class H (2696) Income Statement

8 Followers

Shanghai Henlius Biotech, Inc. Class H Income Statement

Last quarter (Q2 2026), Shanghai Henlius Biotech, Inc. Class H's total revenue was ¥1.79B, an increase of 27.26% from the same quarter last year. In Q2, Shanghai Henlius Biotech, Inc. Class H's net income was ¥215.22M. See Shanghai Henlius Biotech, Inc. Class H’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 6.67B¥ 5.72B¥ 5.39B¥ 3.21B¥ 1.68B
¥ 4.98B¥ 4.18B¥ 3.92B¥ 2.37B¥ 1.16B
¥ 4.17B¥ 3.25B¥ 3.29B¥ 3.00B¥ 1.82B
Depreciation and Amortization¥ 429.41M¥ 374.80M¥ 359.23M¥ 277.60M¥ 200.18M
¥ 1.25B¥ 1.24B¥ 990.94M¥ -310.61M¥ -671.74M
¥ 817.12M¥ 939.13M¥ 631.70M¥ -628.53M¥ -665.25M
¥ -5.40M¥ -93.25M¥ -62.13M¥ -65.36M¥ -291.49M
¥ 811.72M¥ 845.88M¥ 569.58M¥ -693.89M¥ -956.74M
¥ 805.64M¥ 820.47M¥ 546.02M¥ -695.26M¥ -984.05M
Per Share Metrics
Basic EPS¥ 1.47¥ 1.51¥ 1.00¥ -1.28¥ -1.83
Diluted EPS¥ 1.47¥ 1.51¥ 1.00¥ -1.28¥ -1.83
Weighted Average Shares Outstanding545.93M543.49M543.37M542.02M537.73M
Weighted Average Shares Outstanding (Diluted)545.93M543.49M543.37M542.02M538.84M

Currency in CNY

Shanghai Henlius Biotech, Inc. Class H Earnings and Revenue History

-4B04B8B-8000 %-4000 %0 %4000 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin